Ardent Health Partners, LLC
NYSE:ARDTMedical - Care Facilities
-$0.14 today
- Market cap
- $2.03B
- Beta
- 0.84
- P/E (TTM)
- 9.4
- EPS (TTM)
- $0.95
Volume 7.27M
Average 0.45M
ARDT Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Ardent Health Partners, LLCNYSE: ARDT
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue grows in line with its trailing trend
Q1 FY2026 revenue of $1.6B rose 7.0% year over year, in line with the +6.7% change in trailing-twelve-month revenue. Sequentially, it fell 0.2% from the prior quarter. Over 3 fiscal years it compounded at +7.2% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 9 analysts of $6.49B (+2.6%) for the fiscal year ending Dec 2026, a slowdown from the +6.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $1.6B-0.2% QoQ
- Last fiscal yearDec 2025
- $6.32B+6.0% YoY
- LTMMar 2026
- $6.43B+6.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +7.0% | -3.4% | -10.4 pp |
| 1 year | +6.0% | +2.6% | -3.4 pp |
| 3-year CAGR | +7.2% | +3.2% | -4.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 6.32B USD
- Year-over-year change
- +6.0%
- 4-year CAGR
- +6.7%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.32B | +6.0% |
| FY2024 | 2024-12-31 | 5.97B | +10.3% |
| FY2023 | 2023-12-31 | 5.41B | +5.5% |
| FY2022 | 2022-12-31 | 5.13B | +5.3% |
| FY2021 | 2021-12-31 | 4.87B | — |
Revenue vs competitors
How ARDT compares with its peers on the latest reported figures
- ARDT's LTM Mar 2026 revenue of $6.43B is the highest of the 11 companies compared; the peer median is $2.32B.
- Its year-over-year change of +6.7% is the 7th highest of 11, against a peer median of +16.4%.
- Over three fiscal years its annual growth of +7.2% compares with a peer median of +11.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $6.43B | +6.7% | +7.2% |
| LTM Mar 2026 | $5.52B | +29.2% | -4.9% | |
| LTM Mar 2026 | $3.53B | +56.7% | +40.6% | |
| LTM Sep 2026 | $3.41B | +4.5% | +8.3% | |
| LTM Sep 2026 | $2.95B | -5.4% | +4.4% | |
| LTM Oct 2026 | $2.68B | +16.8% | +10.8% | |
| LTM Sep 2026 | $1.96B | +1.9% | -1.0% | |
| LTM Jun 2026 | $1.58B | +20.4% | +18.3% | |
| LTM Sep 2026 | $1.58B | +5.6% | +12.2% | |
| LTM Jun 2026 | $1.48B | +15.9% | +14.4% | |
| LTM Sep 2026 | $182.57M | +121.2% | +678.6% | |
| Peer median (excluding ARDT) | $2.32B | +16.4% | +11.5% | |
Competitors are the stored peer set for ARDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.87B | 5.13B | 5.41B | 5.97B | 6.32B |
| Cost of Revenue | 927.33M | 955.17M | 140.84M | 1.03B | 155.7M |
| Gross Profit | 3.94B | 4.17B | 5.27B | 4.93B | 6.17B |
| Gross Margin | 81.0% | 81.4% | 97.4% | 82.7% | 97.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 3.13B | 3.37B | 3.62B | 3.88B | 1.19B |
| Operating Expenses | 3.51B | 3.96B | 5.04B | 4.53B | 5.84B |
| Depreciation & Amortization | 137.2M | 138.17M | 140.84M | 146.29M | 155.7M |
| EBITDA | 526.93M | 531.7M | 350M | 574.93M | 497.26M |
| EBITDA Margin | 10.8% | 10.4% | 6.5% | 9.6% | 7.9% |
| Operating Income | 436.56M | 217.03M | 229.5M | 405.76M | 325.58M |
| Operating Margin | 9.0% | 4.2% | 4.2% | 6.8% | 5.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 93.83M | 82.05M | 65.43M | 65.58M | 55.2M |
| Other Income / Expenses | (140.68M) | 94.45M | (77.89M) | (42.7M) | (39.23M) |
| Income Before Tax | 295.89M | 311.48M | 151.61M | 363.06M | 286.36M |
| Pre-Tax Margin | 6.1% | 6.1% | 2.8% | 6.1% | 4.5% |
| Income Tax Expense | 51.31M | 46.11M | 22.64M | 63.35M | 56.22M |
| Net Income | 154.26M | 188.91M | 50.29M | 210.34M | 135.81M |
| Net Margin | 3.2% | 3.7% | 0.9% | 3.5% | 2.1% |
| EPS (Basic) | 1.08 | 1.32 | 0.35 | 1.59 | 0.96 |
| EPS (Diluted) | 1.08 | 1.32 | 0.35 | 1.58 | 0.96 |
| Weighted Avg Shares | 143.26M | 143.26M | 143.26M | 132.44M | 140.76M |
| Weighted Avg Shares (Diluted) | 143.26M | 143.26M | 143.26M | 132.75M | 141.45M |
Ardent Health Partners, LLC
NYSE:ARDT
Intrinsic Alpha fair value
Locked
Current Price
$14.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.